Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7382 p4
7 January 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Intensive treatment reduces cardiovascular disease risk in type 1 diabetes

Intensive diabetes treatment reduces the long-term risk of cardiovascular disease in patients with type 1 diabetes, new data have confirmed (New England Journal of Medicine 2005;353:2643).

Over a mean of 17 years of following patients in the Diabetes Control and Complications Trial, researchers found that intensive treatment reduced the risk of any cardiovascular disease event by 42 per cent (95 per cent confidence interval, 9–63 per cent; P=0.02) and the risk of non-fatal myocardial infarction, stroke or death from cardiovascular disease by 57 per cent (12–79; P=0.02).

Back to Top


©The Pharmaceutical Journal